Health technology deals with all aspects of healthcare, from preventive programs (vaccination drives), and diagnostic tests, to the development of devices or parts of equipment, drugs, or any medical procedure. Health technology assessment (HTA) entails a systematic appraisal of the short- and long-term outcomes of healthcare technologies. HTA provides information on various aspects of the […]
Privacy Policy
MedPro Clinical Research
Website: https://crmedpro-eu.com
Effective Date: 24th February 2026
MedPro Clinical Research (“MedPro”, “we”, “us”, or “our”) is committed to protecting and respecting your privacy.
This Privacy Policy explains how we collect, use, disclose, and protect personal data when you:
This policy complies with:
The data controller responsible for your personal data is:
MedPro Clinical Research
Website: https://crmedpro-eu.com
Postal Address: MedPro Clinical Research, 34A Rutland Road, Maidenhead, SL64HY
If you have any questions regarding this Privacy Policy or wish to exercise your rights, please contact us using the details above.
In accordance with Article 5 GDPR, we process personal data in line with the following principles:
These principles are embedded within our Information Security Management System (ISMS).
Depending on your interaction with us, we may collect:
4.1 Identity & Contact Information
4.2 Professional & Business Information
4.3 Technical & Website Data
(See our Cookies Policy for more information.)
4.4 Recruitment Data
If you apply for employment, we may collect:
4.5 Special Category Data
We do not intentionally collect special category data (e.g., health, racial origin, political beliefs) via our website.
If such data is required in a recruitment or contractual context, it will only be processed:
We collect personal data:
We process personal data under the following lawful bases:
6.1 Contractual Necessity (Article 6(1)(b))
6.2 Legitimate Interests (Article 6(1)(f))
We conduct Legitimate Interest Assessments (LIA) where required.
6.3 Consent (Article 6(1)(a))
You may withdraw consent at any time.
6.4 Legal Obligation (Article 6(1)(c))
We use your data to:
We will not process your data for purposes incompatible with the original purpose without informing you.
We may send marketing communications where:
You may opt out at any time via:
We may share personal data with:
All third parties are subject to confidentiality and data protection obligations under written agreements.
As a clinical research organisation operating internationally, your data may be transferred outside the EEA or UK.
Where transfers occur, we implement appropriate safeguards, including:
MedPro Clinical Research implements appropriate technical and organisational measures including:
We maintain documented information security policies as part of our ISMS framework.
We retain personal data only as long as necessary:
Retention periods may vary where legal or contractual requirements apply.
Under GDPR and UK GDPR, you have the right to:
EU residents: Contact your local Data Protection Authority.
UK residents: Contact the Information Commissioner’s Office (ICO).
In the event of a personal data breach, we will:
Our website may contain links to third-party websites. We are not responsible for their privacy practices.
We may update this Privacy Policy periodically. Updates will be published on this page with a revised effective date.
MedPro Clinical Research
Website: https://crmedpro-eu.com
Effective Date: 24th February 2026
These Terms of Service (“Terms”) govern your access to and use of the website operated by MedPro Clinical Research (“MedPro”, “we”, “us”, or “our”).
By accessing or using this website, you agree to be bound by these Terms. If you do not agree, you must discontinue use immediately.
We reserve the right to amend these Terms at any time. Updates will be posted on this page with a revised effective date. Continued use of the website constitutes acceptance of the updated Terms.
This website provides:
Information about MedPro Clinical Research
Details about our clinical research and consulting services
Business and professional contact opportunities
Recruitment information
Nothing on this website constitutes medical advice, clinical advice, or regulatory advice unless expressly stated.
You must:
Be at least 18 years old
Use the website only for lawful purposes
Not use the website in any way that violates applicable laws or regulations
All content on this website, including:
Text
Graphics
Logos
Service marks
Trademarks
Images
Software
Layout and design
is the property of MedPro Clinical Research or its licensors and is protected by copyright, trademark, and other intellectual property laws.
You may:
View content for personal or internal business purposes
Print or download extracts for non-commercial use
You may not:
Reproduce, distribute, modify, or commercially exploit content
Mirror or frame the website
Remove copyright or proprietary notices
No license or ownership rights are transferred to you.
All trademarks, logos, and brand elements displayed on this website are the property of MedPro Clinical Research or third parties.
Use of any trademark without prior written consent is strictly prohibited.
You agree not to:
Attempt unauthorised access to systems or data
Introduce malicious software (viruses, trojans, etc.)
Interfere with website functionality
Use automated systems (bots/scrapers) without permission
Upload unlawful, defamatory, or infringing content
We reserve the right to suspend or restrict access for violations.
Your use of the website is also governed by our Privacy Policy and Cookies Policy.
We process personal data in accordance with:
EU GDPR
UK GDPR
Data Protection Act 2018
PECR
We implement appropriate technical and organisational security measures aligned with ISO/IEC 27001:2022 principles.
If you submit information to us (including inquiries, feedback, or job applications):
You confirm that the information is accurate
You grant us the right to process that information for legitimate business purposes
You confirm you have the authority to share such information
Confidential information should not be submitted unless explicitly requested through secure channels.
By contacting us electronically, you consent to receive communications electronically.
We may communicate with you by:
Website notices
Contractual documentation
Electronic communications satisfy any legal requirement for written communication where permitted by law.
Our website may contain links to third-party websites.
We:
Do not control third-party websites
Are not responsible for their content
Do not endorse third-party services unless explicitly stated
Use of third-party websites is at your own risk.
To the maximum extent permitted by law:
The website is provided on an “as is” and “as available” basis
We make no warranties regarding accuracy, completeness, or reliability
We do not guarantee uninterrupted or error-free operation
Nothing in these Terms excludes liability that cannot legally be excluded under applicable law.
To the extent permitted by law, MedPro Clinical Research shall not be liable for:
Indirect or consequential losses
Loss of profits or business
Loss of data
Business interruption
Nothing in these Terms excludes liability for:
Death or personal injury caused by negligence
Fraud or fraudulent misrepresentation
Any liability that cannot legally be excluded under EU or UK law
In line with our information security obligations, including ISO/IEC 27001 principles, we:
Monitor systems for security threats
Maintain protective technical controls
Log and investigate suspicious activity
Unauthorised attempts to access or interfere with our systems may result in legal action.
As a clinical research organisation, we operate within applicable regulatory frameworks. Information on this website is provided for general informational purposes and does not replace formal contractual or regulatory documentation.
These Terms shall be governed by and interpreted in accordance with:
The laws of [Insert EU Member State or UK jurisdiction]
Any disputes shall be subject to the exclusive jurisdiction of the courts of that jurisdiction.
If you believe content on this website infringes your intellectual property rights, please contact us with:
Your contact details
Description of the alleged infringement
Evidence of ownership
The exact URL of the material
We will investigate and take appropriate action in accordance with applicable intellectual property laws.
We reserve the right to modify these Terms at any time. Updated versions will be published on this page with a revised effective date.
Continued use of the website constitutes acceptance of any changes.
Cookies Policy
MedPro Clinical Research
Website: https://crmedpro-eu.com
Effective Date: 24th February 2026
This Cookies Policy explains how MedPro Clinical Research (“MedPro”, “we”, “us”, or “our”) uses cookies and similar tracking technologies on our website.
This policy is designed to comply with:
We are committed to ensuring transparency, lawful processing, and appropriate technical and organisational safeguards in relation to personal data collected through cookies.
Cookies are small text files stored on your device when you visit a website. They allow the website to:
Cookies may be:
Under GDPR and UK GDPR, we process cookie-related personal data based on:
3.1 Strictly Necessary Cookies
Legal Basis:
Consent is not required for strictly necessary cookies.
3.2 Analytics, Advertising, and Social Media Cookies
Legal Basis:
These cookies are only activated after you provide explicit consent through our cookie consent mechanism.
You may withdraw consent at any time.
4.1 Strictly Necessary Cookies
These cookies are essential for:
Without these cookies, the website cannot function properly.
Retention: Session-based or limited duration.
4.2 Performance & Analytics Cookies
We use analytics tools such as Google Analytics to collect aggregated statistical information, including:
IP anonymisation is enabled where applicable.
These cookies are deployed only after user consent.
Retention: As defined by the provider (typically up to 26 months unless configured otherwise).
4.3 Functionality Cookies
These cookies remember user preferences such as:
Retention: Persistent (limited duration).
4.4 Social Media Cookies
Our website includes social media sharing features from:
If you interact with these plugins, the relevant platform may collect data about your visit.
We do not control how these third parties process your personal data. Please refer to their privacy policies.
These cookies are set only after consent.
4.5 Advertising & LinkedIn Tracking Technologies
We use tracking technologies provided by LinkedIn, including:
Purpose:
Categories of data processed may include:
Some server-side tracking technologies may not be blocked by browser-based ad blockers.
These cookies and tracking tools are activated only after explicit consent.
You can manage advertising preferences via your LinkedIn account.
Some of our third-party service providers (e.g., analytics and advertising partners) may process personal data outside the European Economic Area (EEA) or the United Kingdom.
Where such transfers occur, we ensure appropriate safeguards are implemented, including:
In alignment with ISO/IEC 27001:2022 principles, MedPro Clinical Research implements:
Third-party providers are subject to due diligence and contractual safeguards.
You have the right to:
You may:
Please note: Blocking certain cookies may impact website functionality.
Under GDPR and UK GDPR, you have the right to:
For EU residents: You may contact your local Data Protection Authority.
For UK residents: You may contact the Information Commissioner’s Office (ICO).
We may update this Cookies Policy periodically to reflect changes in legal requirements, technology, or business practices.
Any changes will be published on this page with an updated effective date.
Please update your information and we will send you the Webinar Link in your email
Haruyoshi Ogata
Haruyoshi has had extensive experience working with key persons across pharmaceutical and medical device companies, publishers, editorial boards, international societies, and KOLs. With over 20 years of experience in business development and marketing across multiple industries, he has shared his expertise with many clients.
Haruyoshi has knowledge of publishing industries, business communication, and culture of Japan as well as the APAC region. As the manager of business development for a global publisher, he launched the science communication department. During this period, he conducted educational seminars for publication ethics and publication planning. He also has in-depth experiences as a branch manager in the publication industry of Australia for three years.
Haruyoshi has served as Director, Business Development, at one of the global medical communication agencies and has been involved in over 100 scientific publication projects and the launch of international journals. In addition, he has expertise in publication strategies, pub SOP, and policy developments.
Haruyoshi has been a part of the medical communications team (including medical writing) that aided pharmaceutical and medical device companies, which published work by Japanese clinical researches and studies in global journals. He has helped to publish several articles and supplements in journals.
K. G. Mathew Tharakan
VICE PRESIDENT - GOVERNMENT SOLUTIONS
Mathew has 30 years of experience in transportation operations and engineering management along with professional expertise in rail vehicle engineering at Southeastern Pennsylvania Transportation Authority (SEPTA). In 2016, he joined SEPTA’s business division as a Disadvantaged Business Enterprise Manager, overseeing the participation of minority and women-owned businesses in procurement and major construction contracts.
As part of a cost-saving strategy, Mathew was asked to set up a new material warranty department for SEPTA. He was additionally tasked with the rewriting of SOPs and policies for their supply chain division. For over three decades, he has occupied various Asian American leadership positions, particularly Indian American community leadership roles in Philadelphia and Bucks and Montgomery counties.
Mathew graduated from the 2013 Pennsylvania Political Leaders Fellowship Program (CPL), and has extensively travelled and researched the Pennsylvania political landscape. Nationally, he was involved in grassroot organizing, fundraising, faith-based initiatives, and President Obama’s Asian American affairs and White House community partnership program. Moreover, he has served as the president of Conference of Minority Transportation Officials, a national organization with 40 chapters across the United States that is committed to the diversity and progress of minorities in the transportation industry. He further co-chaired Mayor Kenney’s transportation and infrastructure transition committee and was appointed as a member of the mayor’s advisory commission on Asian American affairs in July 2016.
In 2018, Mathew was asked to serve on the Bucks county transportation commission to assist with the Middletown township’s traffic development program. He has an MBA in finance and a master’s in computer science from Philadelphia University. In addition, he has a bachelor’s degree in history and political science from Loyola College University, Madras, and a diploma in electrical technology from Kerala University.
At Bioviser, Mathew supports business development activities for government solutions with prime contractors for data analytics. He is presently working on his doctoral program in business administration with an emphasis in data analytics.
CHIEF FINANCIAL OFFICER (CFO)
Roque is a natural-born leader and has been successfully running a leading emergency and medical care practice for 27 years in Virginia, USA. Additionally, having earned his degree from Bombay Veterinary College in 1977, he has been actively practicing veterinary medicine for 44 years. Among his many achievements, Roque is a member of the DC Academy of Veterinary Medicine.
As a business owner, Roque has been safeguarding the vital assets of his company by reducing risks and accurately maintaining/closing books; operating an efficient and effective financial structure through planning, analysis, and remedial measures; strategizing in various ways to influence the future direction of his company; and stimulating and driving business growth initiatives such as improved company cost reduction, procurement, pricing execution, and other innovations adding value to the company. Additionally, he has been making decisions related to team recruitment and people management, patient records, and compliance to IRS and OSHA standards. Further, he has been regularly attending national and international conferences.
As the CFO at Bioviser, Roque is primarily responsible for providing financial leadership and aligning business and finance strategies to grow the business. When he is not working, Roque loves to garden, bike, visit national parks, and travel to other countries.
We have sent you the downloadable pdf on your email address. Please check your inbox.
We have received your details. We will get in touch with you.
Please update your information and we will get in touch with you shortly
Please update your information and we will send you the pdf in your email
Haruyoshi has had extensive experience working with key persons across pharmaceutical and medical device companies, publishers, editorial boards, international societies, and KOLs. With over 20 years of experience in business development and marketing across multiple industries, he has shared his expertise with many clients.
Haruyoshi has knowledge of publishing industries, business communication, and culture of Japan as well as the APAC region. As the manager of business development for a global publisher, he launched the science communication department. During this period, he conducted educational seminars for publication ethics and publication planning. He also has in-depth experiences as a branch manager in the publication industry of Australia for three years.
Haruyoshi has served as Director, Business Development, at one of the global medical communication agencies and has been involved in over 100 scientific publication projects and the launch of international journals. In addition, he has expertise in publication strategies, pub SOP, and policy developments.
Haruyoshi has been a part of the medical communications team (including medical writing) that aided pharmaceutical and medical device companies, which published work by Japanese clinical researches and studies in global journals. He has helped to publish several articles and supplements in journals.
Emilie holds a Master’s in Global Health and brings international experience in public health, strategic advisory, and cross-sectoral collaboration. Her experience spans organizations like Medtronic and other leading health institutions, where she has successfully led transformative initiatives, designed evidence-based strategies, and built impactful partnerships that translate knowledge into action for policy and decision-making.
Having lived and worked between Delhi and Copenhagen, Emilie offers a unique perspective on translating global insights into solutions for the Nordic and European context. Her work spans designing locally tailored solutions that advance health equity, strengthen sustainable health systems, and improve care delivery. She is passionate about leveraging innovative and collaborative approaches to deliver impact and support growth.
Outside of work, Emilie loves culture, art, music, and dance, enjoys exploring new places and nature, and is currently learning Hindi. She is passionate about community engagement, having worked in Ecuador on reforesting parts of the Amazon rainforest and in Nicaragua coordinating a Solidarity Brigade to support the social and sustainable development of low-income communities – an experience that also strengthened her Spanish proficiency while navigating complex, intersectional challenges. Additionally, she has collaborated with refugees on book projects in partnership with the Red Cross, working to bring forward the voices of underserved communities. Based in Copenhagen, she’s always happy to connect.
A pharmacist by qualification, Santhosh has a master’s degree in pharmaceutics from Cromwell College, UK. Also, he has an M.S. in general chemistry from MTSU, USA. At MTSU, he was awarded graduate assistantship for two years for achieving high GPAs. He has over 14 years of experience in managing operations and delivery systems in the clinical research and drug safety industry. He also has extensive experience in pharmacovigilance, data analysis, and clinical research. He has proven himself as a successful delivery manager with competent team management skills.
Over the last five years, Santhosh earned a reputation for providing scalable business operational solutions that meet demanding time constraints and exceed expectations. He has worked with numerous prestigious organizations such as Accenture, Novartis, Syneos Health (formerly known as InVentiv), and Cognizant Technology Solutions Pvt. Ltd. His expertise lies in streamlining quality operations and controlling and coordinating for the improvement of deliverables.
As an SME, Santhosh has sound knowledge of pharmacovigilance and regulatory activities. He is an experienced corporate global trainer who has trained over 150 associates in pharmacovigilance across the globe.
Santhosh has headed an independent quality control team at the portfolio level, has been responsible for multiple accounts, and has acted as a BQA (preparing for audits, facing client audits, conducting internal audits, and highlighting risks). He has been actively involved in determining, negotiating, and agreeing on in-house quality procedures, standards, and specifications as well as assessing customer requirements and ensuring that they are met. He has participated in important activities such as setting customer service standards, investigating and setting standards for quality, and ensuring that processes comply with standards at both national and international levels. He has closely worked with cross-functional teams to establish standards, systems and procedures, writing management and technical reports, and customer’s charters; to determine training needs; and to implement proposed CAPAs. He has acted as a catalyst for change and improvement in performance and quality.
Over the years, Ivan has built a solid multifunctional foundation in the healthcare industry, working at various leadership positions. He has lent his expertise to strategy, business and product offering expansion, team building, sales, delivery, client servicing, training and development, and recruitment.
With over 15 years of experience in business, Ivan has been a significant contributor to the growth of numerous businesses. He has consulted clients for clinical research solutions in India and has continued to grow such services in major markets like the US, EU, and Japan along with growing business regions such as China, Taiwan, South Korea, and India.
Ivan has built teams in these regions and extensively travelled to manage numerous customer relationships with budgets of millions of dollars. His strengths lie in customizing solutions; one of his greatest achievements was to design a customized business solution in pharmacovigilance with a novel partnering idea that won his company a deal of over $10M.
Beyond Bioviser, Ivan maintains an active presence in the industry ecosystem by being a member on numerous forums. He loves supporting and encouraging entrepreneurship. He also serves as a member of a few clinical research ventures’ advisory boards and helps accelerate their journey to commercial success. Despite several work commitments, Ivan loves to carve out time to share a wealth of knowledge with his industry peers and is a guest lecturer at various leading clinical research institutes. Additionally, he is a speaker at industry conferences on clinical research.
